Study Stopped
Lack of funding and recruitment.
Prevention of Phantom Limb Pain After Transtibial Amputation
PLATA
1 other identifier
interventional
12
5 countries
9
Brief Summary
Phantom limb pain following amputation is a major problem. Current evidence how to best prevent phantom limb pain is equivocal because previous trials have included small numbers of patients, and tested heterogeneous patient collectives. There is some evidence that optimized perioperative pain control is effective in preventing phantom limb pain, but the potential added role of regional anesthesia has not been defined. Objective: The Aim of this study is to test the hypothesis that sciatic nerve block decreases the point prevalence of phantom limb pain 12 months after transtibial amputation for peripheral vascular disease compared to optimized intravenous pain therapy. Study design: Randomized, prospective, double-blind (patient, physician, statistician) clinical trial. All patients will receive standard optimized intravenous anesthesia and analgesia (opiate patient-controlled analgesia (PCA), intravenous ketamine). Patients in the intervention group will receive additional infusion of local anesthetic via a sciatic nerve catheter placed under ultrasound guidance. Main outcome of this study: Point prevalence of chronic phantom limb pain after 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2013
Longer than P75 for not_applicable
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2012
CompletedFirst Posted
Study publicly available on registry
June 25, 2012
CompletedStudy Start
First participant enrolled
August 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedOctober 27, 2017
October 1, 2017
3.7 years
June 21, 2012
October 25, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Point prevalence of chronic phantom limb pain
12 months after amputation
Study Arms (2)
Nerve block
EXPERIMENTALOptimized intravenous pain treatment during surgery and for 7 days postoperatively. Definition: strong opioid patient-controlled analgesia, non-opioids, ketamine intravenously. Sciatic nerve block: infusion of local anesthetic.
Control
ACTIVE COMPARATOROptimized intravenous pain treatment during surgery and for 7 days postoperatively. Definition: strong opioid patient-controlled analgesia, non-opioids, ketamine intravenously. Sciatic nerve block: saline infusion.
Interventions
Eligibility Criteria
You may qualify if:
- patients undergoing elective transtibial amputation for peripheral vascular disease
- age over 18 years
- American Society of Anaesthesiology status II to IV
You may not qualify if:
- contraindication to peripheral regional anesthesia
- psychiatric disease
- pregnancy or breastfeeding status
- amputation for tumour surgery
- traumatic amputation
- inability to give written and informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (9)
Massachusetts General Hospital, Dept. of Anesthesiology, Perioperative and Pain Medicine
Boston, Massachusetts, 02115, United States
General Hospital Klagenfurt
Klagenfurt, Carinthia, Austria
Innsbruck Medical University Hospital
Innsbruck, Tyrol, 6020, Austria
Ziekenhuis Oost Limburg
Genk, Limburg, Belgium
Academic Medical Center, University of Amsterdam
Amsterdam, North Holland, 1105AZ, Netherlands
Westfriesgasthuis
Hoorn, North Holland, Netherlands
Erasmus Medical Center
Rotterdam, North Holland, Netherlands
Canisius Wilhelmus Ziekenhuis
Nijmegen, Netherlands
Valencia University Hospital
Valencia, Spain
Related Publications (2)
Ypsilantis E, Tang TY. Pre-emptive analgesia for chronic limb pain after amputation for peripheral vascular disease: a systematic review. Ann Vasc Surg. 2010 Nov;24(8):1139-46. doi: 10.1016/j.avsg.2010.03.026.
PMID: 20800987BACKGROUNDRathmell JP, Kehlet H. Do we have the tools to prevent phantom limb pain? Anesthesiology. 2011 May;114(5):1021-4. doi: 10.1097/ALN.0b013e31820fc80d. No abstract available.
PMID: 21383618BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Markus Hollmann, MD PhD
Dept. of Anaesthesiology, Academic Medical Center / University of Amsterdam, The Netherlands
- PRINCIPAL INVESTIGATOR
Philipp Lirk, MD PhD
Dept. of Anaesthesiology, Academic Medical Center / University of Amsterdam, The Netherlands
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Attending Anesthesiologist
Study Record Dates
First Submitted
June 21, 2012
First Posted
June 25, 2012
Study Start
August 1, 2013
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
October 27, 2017
Record last verified: 2017-10